Assessment and characteristics of Erenumab therapy on migraine management by Haitham Saeed, Alaa S. Tulbah, Amr Gamal, Marwa Kamal

Subjects: “…Erenumab…”
Get full text

Migraine Treatment Using Erenumab: Can Lead to a Cognitive and Psychological Qualitative Improvement? by Michele Torrisi, Francesco Corallo, Viviana Lo Buono, Marcella Di Cara, Rosario Grugno, Riccardo Lo Presti, Angelo Quartarone, Maria Cristina De Cola

Subjects: Get full text

Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study by Licia Grazzi, Riccardo Giossi, Danilo Antonio Montisano, Mattia Canella, Marilena Marcosano, Claudia Altamura, Fabrizio Vernieri

Subjects: Get full text

The course of headache after the end of treatment with erenumab in patients with episodic and chronic migraine by Anna A. Garmanova, Anna V. Berdnikova, Nina V. Latysheva

Subjects: Get full text

Efficacy and safety of erenumab in the preventive treatment of migraine in adults: a systematic review by Yan LIN, Deng CHEN, Da XU, Ling LIU

Subjects: Get full text

Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study by Charly Gaul, Astrid Gendolla, Dagny Holle, Hartmut Göbel, Mirja Koch, Caroline Baufeld, Cordula Weiss

Subjects: “…Erenumab…”
Get full text

Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence by Abubker Omaer, Abdulrazaq Albilali, Reem Bamogaddam, Fares Almutairi, Raghad Alsaif, Osama Almohammadi, Abdullah A Alhifany

Subjects: Get full text

A retrospective analysis of migraine prophylaxis with anti-CGRP monoclonal antibodies at the hospital of Lithuanian University of Health Sciences Kaunas Clinics by V. Karpavičiūtė, K. Statkevičienė, G. Žemgulytė

Subjects: Get full text

Real-world effectiveness of erenumab in Japanese patients with migraine by Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, Yasuo Haruyama, Saro Kobayashi, Mukuto Shioda, Koichi Hirata

Subjects: Get full text

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention by Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti

Subjects: Get full text

Experience with erenumab: Data from real clinical practice by E. Morales Bacas, J.C. Portilla Cuenca, V. Romero Cantero, I. García Gorostiaga, M. Martínez Acevedo, I. Casado-Naranjo

Subjects: Get full text

Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World... by Robert Urman, Nicole Princic, Fiston Vuvu, Leah B. Patel, Sam Oh, David Chandler, Nada Hindiyeh, Mark E. Bensink

Subjects: Get full text

Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany by Andreas Straube, Philipp Stude, Charly Gaul, Katrin Schuh, Mirja Koch

Subjects: “…Erenumab…”
Get full text

Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data by Antun R. Pavelic, Christian Wöber, Franz Riederer, Karin Zebenholzer

Subjects: Get full text

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study by Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Anna P. Andreou, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Nina Latysheva, Elena Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Simona Sacco

Subjects: “…Erenumab…”
Get full text

Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis by Armin Scheffler, Jale Basten, Lennart Menzel, Dominik Binz, Wolfgang Alexander Becker, Vincent Breunung, Hannah Schenk, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Dagny Holle

Subjects: “…Erenumab…”
Get full text

Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study by Keiko Ihara, Seiya Ohtani, Narumi Watanabe, Nobuyuki Takahashi, Naoki Miyazaki, Kei Ishizuchi, Satoko Hori, Ryo Takemura, Jin Nakahara, Tsubasa Takizawa

Subjects: Get full text

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study by Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, Stephanie J. Nahas

Subjects: Get full text

Initial experience with novel CGRP-receptor inhibitor therapy in Migraine in the United Arab Emirates: a retrospective observational study by Bui Bao Khanh Dinh, Waseem Hamed Aziz, Alessandro Terruzzi, Derk Wolfgang Krieger

Subjects: Get full text

Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study by Gaia Pellitteri, Sara Pez, Sara Pez, Annacarmen Nilo, Andrea Surcinelli, Gian Luigi Gigli, Gian Luigi Gigli, Christian Lettieri, Mariarosaria Valente, Mariarosaria Valente

Subjects: Get full text